BEVACIZUMAB

Clinical trials for BEVACIZUMAB explained in plain language.

Never miss a new study

Get alerted when new BEVACIZUMAB trials appear

Sign up with your email to follow new studies for BEVACIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

Double-Dose drug combo tested to fight tough lung cancer mutation

Disease control Completed

This study tested a combination of two drugs, bevacizumab and a double dose of icotinib, as a first treatment for people with advanced non-squamous non-small cell lung cancer (NSCLC) who have a specific genetic change called an EGFR L858R mutation. The main goal was to see if thi…

Matched conditions: BEVACIZUMAB

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

BEVACIZUMAB

Get alerted when new BEVACIZUMAB trials appear

Double-Dose drug combo tested to fight tough lung cancer mutation